Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North Carolina

Dan-Yu Lin, Yu Gu, Bradford Wheeler, Hayley Young, Shannon Holloway, Shadia Khan Sunny, Zack Moore, Donglin Zeng
doi: https://doi.org/10.1101/2021.10.25.21265304

Article Information

doi 
https://doi.org/10.1101/2021.10.25.21265304
History 
  • October 26, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Dan-Yu Lin, Ph.D.1,*,
  2. Yu Gu, B.S.1,
  3. Bradford Wheeler, M.P.H.2,
  4. Hayley Young, M.P.H.2,
  5. Shannon Holloway, Ph.D.3,
  6. Shadia Khan Sunny, M.D., Ph.D., M.P.H.2,
  7. Zack Moore, M.D., M.P.H.2 and
  8. Donglin Zeng, Ph.D.1
  1. 1University of North Carolina at Chapel Hill Gillings School of Global Public Health
  2. 2North Carolina Department of Health and Human Services
  3. 3North Carolina State University
  1. ↵*Address correspondence to Dr. Dan-Yu Lin, Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599-7420, USA. Email: lin{at}bios.unc.edu
Back to top
Posted October 26, 2021.
Download PDF
Data/Code
Email
Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North Carolina
Dan-Yu Lin, Yu Gu, Bradford Wheeler, Hayley Young, Shannon Holloway, Shadia Khan Sunny, Zack Moore, Donglin Zeng
medRxiv 2021.10.25.21265304; doi: https://doi.org/10.1101/2021.10.25.21265304
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area